Matrix metalloproteinases and arterial hypertension: role of oxidative stress and nitric oxide in vascular functional and structural alterations

AF Prado, RIM Batista, JE Tanus-Santos, RF Gerlach - Biomolecules, 2021 - mdpi.com
Various pathophysiological mechanisms have been implicated in hypertension, but those
resulting in vascular dysfunction and remodeling are critical and may help to identify critical …

MMP-2 and its implications on cardiac function and structure: interplay with inflammation in hypertension

TR Vitorino, AF do Prado, SB de Assis Cau… - Biochemical …, 2023 - Elsevier
Hypertension is one of the leading risk factors for the development of heart failure. Despite
being a multifactorial disease, in recent years, preclinical and clinical studies suggest strong …

[HTML][HTML] Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications

Y Hua, S Nair - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2015 - Elsevier
Cardiovascular disease is the leading cause of death in the US and other developed
countries. Metabolic syndrome, including obesity, diabetes/insulin resistance, hypertension …

[HTML][HTML] Roles of biomarkers in myocardial fibrosis

Y Ding, Y Wang, W Zhang, Q Jia, X Wang, Y Li… - Aging and …, 2020 - ncbi.nlm.nih.gov
Myocardial fibrosis is observed in various cardiovascular diseases and plays a key role in
the impairment of cardiac function. Endomyocardial biopsy, as the gold standard for the …

Matrix metalloproteinases are involved in cardiovascular diseases

A Azevedo, AF Prado, RC Antonio… - Basic & Clinical …, 2014 - Wiley Online Library
This MiniReview describes the essential biochemical and molecular aspects of matrix
metalloproteinases (MMP s) and briefly discusses how they engage in different diseases …

DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats

MA Alam, MRH Chowdhury, P Jain, MAT Sagor… - Diabetology & metabolic …, 2015 - Springer
Background Hyperglycemia and insulin resistance often develop cardiovascular and
nephrological dysfunction in diabetic patients. Sitagliptin is used to treat diabetes and …

Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac …

EV Da Rocha, F Falchetti, L Pernomian… - Naunyn-Schmiedeberg's …, 2023 - Springer
Oxidative stress and MMP activity are found in the hearts and arteries in hypertension and
contribute to the resulting hypertrophy and dysfunction. Quercetin is a flavonoid that reduces …

[HTML][HTML] Cardiac matrix: a clue for future therapy

PK Mishra, S Givvimani, V Chavali, SC Tyagi - Biochimica et Biophysica …, 2013 - Elsevier
Cardiac muscle is unique because it contracts ceaselessly throughout the life and is highly
resistant to fatigue. The marvelous nature of the cardiac muscle is attributed to its matrix that …

Pregnancy hypertension-associated endothelial dysfunction is attenuated by isoflurane anesthesia: Evidence of protective effect related to increases in nitric oxide

SD Rodrigues, MLS da Silva, LZ Martins, SEB Gomes… - Life Sciences, 2023 - Elsevier
Aims Pregnancy hypertension-induced endothelial dysfunction associated with impairment
of nitric oxide (NO) bioavailability and hemodynamic derangements is a challenging for …

Sodium ferulate protects against angiotensin II‐induced cardiac hypertrophy in mice by regulating the MAPK/ERK and JNK pathways

B Hu, JT Song, XF Ji, ZQ Liu… - BioMed Research …, 2017 - Wiley Online Library
Background and Objective. It has been reported that sodium ferulate (SF) has hematopoietic
function against anemia and immune regulation, inflammatory reaction inhibition, inhibition …